A second cell-based study of TMZ-induced mutations found an SBS11-like mutational spectrum only in tumor-derived cells that were deficient in mismatch repair (MMR) (65), suggesting that MMR deficiency may be a mechanistic requirement for SBS11. The gene discussed is MRC1; the disease is neoplasm.